Patient Guide: Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 11 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05388760
Status: ACTIVE_NOT_RECRUITING
Condition: Atopic Dermatitis
Phase: PHASE2

Where You Can Participate

This study is available at 11 locations across the country.

Top locations include:
  • • Brno,
  • • Prague,
  • • Reims, Ardennes
  • • And 8 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1) - Join Clinical Trial NCTNCT05388760

How to Join This Clinical Trial - NCTNCT05388760

Learn how to participate in this PHASE2 trial studying an investigational therapy for Atopic Dermatitis. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Atopic Dermatitis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Atopic Dermatitis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05388760 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 11 locations. Find a study site near you:

Clinical Research Site

Brno, 625 00 - Czechia

Status: Contact for availability

Clinical Research Site

Prague, 150 06 - Czechia

Status: Contact for availability

Clinical Research Site

Reims, Ardennes 51100 - France

Status: Contact for availability

Clinical Research Site

Rotterdam, 3011 TG - Netherlands

Status: Contact for availability

Clinical Research Site

Utrecht, 3584 CX - Netherlands

Status: Contact for availability

Clinical Research Site

Cadiz, Andalusia 11009 - Spain

Status: Contact for availability

Clinical Research Site

Esplugues de Llobregat, Barcelona 08950 - Spain

Status: Contact for availability

Clinical Research Site

Alicante, 03010 - Spain

Status: Contact for availability

Clinical Research Site

Manchester, Greater Manchester M13 9WL - United Kingdom

Status: Contact for availability

Clinical Research Site

London, SE1 9RT - United Kingdom

Status: Contact for availability

And 1 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Atopic Dermatitis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships